(Q38095109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Circulating biomarkers of CNS tumors: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Aysegül Ilhan-Mutlu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ludwig Wagner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

published in

Biomarkers in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

267-285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

Early diagnosis of acute kidney injury: the promise of novel biomarkers

27 February 2020

cites work

1 reference

Biomarkers for serum diagnosis of infectious diseases and their potential application in novel sensor platforms.

21 January 2018

1 reference

Breast cancer screening and biomarkers

21 January 2018

1 reference

Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer

21 January 2018

1 reference

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia

21 January 2018

1 reference

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

21 January 2018

1 reference

CSF and laboratory analysis (tumor markers).

21 January 2018

1 reference

Identification of diagnostic serum protein profiles of glioblastoma patients

21 January 2018

1 reference

Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages

21 January 2018

1 reference

Serum YKL-40 following resection for cerebral glioblastoma

21 January 2018

1 reference

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.

21 January 2018

1 reference

Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.

21 January 2018

1 reference

Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.

21 January 2018

1 reference

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

21 January 2018

1 reference

Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.

21 January 2018

1 reference

Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.

21 January 2018

1 reference

PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.

21 January 2018

1 reference

Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma

21 January 2018

1 reference

Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology

21 January 2018

1 reference

Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth

21 January 2018

1 reference

G-protein coupled receptor-associated sorting protein 1 (GASP-1), a potential biomarker in breast cancer

21 January 2018

1 reference

G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker.

21 January 2018

1 reference

Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis

21 January 2018

1 reference

Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma

21 January 2018

1 reference

Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).

21 January 2018

1 reference

Alexander disease: putative mechanisms of an astrocytic encephalopathy

21 January 2018

1 reference

Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction

21 January 2018

1 reference

Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

21 January 2018

1 reference

Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke

21 January 2018

1 reference

Serum GFAP is a diagnostic marker for glioblastoma multiforme

21 January 2018

1 reference

Neurospecific proteins in the serum of patients with brain tumors.

21 January 2018

1 reference

Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.

21 January 2018

1 reference

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

21 January 2018

1 reference

Exploratory investigation of eight circulating plasma markers in brain tumor patients

21 January 2018

1 reference

Elevated blood markers 1 year before manifestation of malignant glioma

21 January 2018

1 reference

Blood alterations preceding clinical manifestation of glioblastoma.

21 January 2018

1 reference

Cathepsin D is a potential serum marker for poor prognosis in glioma patients.

21 January 2018

1 reference

Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors

21 January 2018

1 reference

Low-molecular weight caldesmon as a potential serum marker for glioma

21 January 2018

1 reference

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients.

21 January 2018

1 reference

Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades

21 January 2018

1 reference

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens

21 January 2018

1 reference

Detection of IDH1 mutation in the plasma of patients with glioma

21 January 2018

1 reference

Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations

21 January 2018

1 reference

2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size

21 January 2018

1 reference

p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.

21 January 2018

1 reference

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls

21 January 2018

1 reference

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

21 January 2018

1 reference

Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor

21 January 2018

1 reference

Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.

21 January 2018

1 reference

The alteration of plasma TGF-β1 levels in patients with brain tumors after tumor removal

21 January 2018

1 reference

Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.

21 January 2018

1 reference

Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors

21 January 2018

1 reference

Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients.

21 January 2018

1 reference

Insulin-like growth factor binding protein 2 promotes glioma development and progression

21 January 2018

1 reference

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas

21 January 2018

1 reference

Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

Decrease in circulating endothelial progenitor cells in treated glioma patients.

21 January 2018

1 reference

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

21 January 2018

1 reference

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide

21 January 2018

1 reference

Increased levels of plasma tissue factor pathway inhibitor in patients with glioblastoma and intracerebral metastases.

21 January 2018

1 reference

Allergies and adult gliomas: cohort results strengthen evidence for a causal association

21 January 2018

1 reference

Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.

21 January 2018

1 reference

Association between prediagnostic IgE levels and risk of glioma

21 January 2018

1 reference

Myxopapillary ependymoma with pleuropulmonary metastases and high plasma glial fibrillary acidic protein levels.

21 January 2018

1 reference

Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study

21 January 2018

1 reference

Plasma netrin-1 is a diagnostic biomarker of human cancers

21 January 2018

1 reference

Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.

21 January 2018

1 reference

CXCL13 and CXCL12 in central nervous system lymphoma patients.

21 January 2018

1 reference

Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers

21 January 2018

1 reference

Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.

21 January 2018

1 reference

CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome

21 January 2018

1 reference

Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma.

21 January 2018

1 reference

The functional and clinical roles of osteopontin in cancer and metastasis.

21 January 2018

1 reference

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor.

21 January 2018

1 reference

Therapy and prophylaxis of brain metastases

21 January 2018

1 reference

Brain metastases: pathobiology and emerging targeted therapies.

21 January 2018

1 reference

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

21 January 2018

1 reference

Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer

21 January 2018

1 reference

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

21 January 2018

1 reference

Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis

21 January 2018

1 reference

Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor.

21 January 2018

1 reference

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

21 January 2018

1 reference

S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.

21 January 2018

1 reference

S100B protein as a possible participant in the brain metastasis of NSCLC.

21 January 2018

1 reference

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

21 January 2018

1 reference

Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors

21 January 2018

1 reference

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer

21 January 2018

1 reference

Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients.

21 January 2018

1 reference

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma

21 January 2018

1 reference

A specific miRNA signature in the peripheral blood of glioblastoma patients

21 January 2018

1 reference

Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas

21 January 2018

1 reference

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee

21 January 2018

1 reference

Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens.

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.5414/NPP27388

Identifiers

DOI

10.2217/BMM.13.12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547822%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference